About
About journal
Goals and objectives
Editorial council
Contacts
Archive
Subscription
To Authors
Copyright agreement
Procedure for reviewing
Requirements for publications
Send article
Privacy Declaration
Conflicts of Interest Declaration
Criteria for authorship
Ethical Standards
ru
en
ISSN 2073–4034
eISSN 2414–9128
About
About journal
Goals and objectives
Editorial council
Contacts
Archive
Subscription
To Authors
Copyright agreement
Procedure for reviewing
Requirements for publications
Send article
Privacy Declaration
Conflicts of Interest Declaration
Criteria for authorship
Ethical Standards
Logout
Sign in
Release
Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Edition number
№20 (333)
№s5-16
№19 (332)
№18 (331)
№17 (330)
№16 (329)
№s4-16
№s3-16
№15 (328)
№14 (327)
№13 (326)
№12 (325)
№11 (324)
№10 (323)
№9 (322)
№8 (321)
№7 (320)
№6 (319)
№5 (318)
№4 (317)
№3 (316)
№s2-16
№2 (315)
№s1-16
№1 (314)
№16 (329) / 2016
M.B. Antsiferov (1), G. Schernthaner (2)
CURRENT APPROACHES TO THERAPY OF TYPE 2 DIABETES MELLITUS IN THE ERA OF NEW DATA ON CARDIOVASCULAR SAFETY
8-16
A.V. Pashentseva, A.F. Verbovoy
OSTEOPOROSIS IN MEN
17-22
L.V. Egshatyan (1), A.M. Mkrtumyan (1), L.A. Zvenigorodskaya (2)
METABOLIC SYNDROME AND INTESTINAL MICROBIOTA
23-28
A.F. Verbovoy, L.A. Sharonova
DIABETES MELLITUS AND CORONARY ARTERY DISEASE: FEATURES OF CLINICAL MANIFESTATION AND TREATMENT.
29-35
M.B. Antsiferov
CLINICAL CHARACTERISTICS AND PRACTICAL ASPECTS OF THE USE OF NEW BASAL INSULIN GLARGINE 300 U/ ML TOUJEO SOLOSTAR®
36-40
A.F. Verbovoy, R.I. Sagirova, Yu. A. Dolgikh, L.A. Sharonova
SOME ASPECTS OF PATHOGENESIS OF INSULIN RESISTANCE
41-45
A.F. Verbovoy, R.I. Sagirova, Yu. A. Dolgikh
OBESITY AND BRONCHIAL ASTHMA
46-49
M.B. Antsiferov (1), V.V. Fadeev (2), T.B. Morgunova (2)
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
50-55
A.M. Mkrtumyan (1), S.V. Podachina (1), M.I. Sviridova (2)
EFFECT OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ON CARDIOVASCULAR RISK MARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
56-61
M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
MOSCOW REGISTRY OF PATIENTS WITH ACROMEGALY: LONG-TERM RESULTS OF OBSERVATIONS
62-66
E.V. Kovrigina (1, 2), V.L. Tyulganova (1, 2)
ADVANTAGES OF THE USE OF INSULIN ASPART IN INSULIN PUMP THERAPY
67-75
M.B. Antsiferov
FEATURES OF USE OF DAPAGLIFLOZIN IN THETREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
76-79
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.
Accept